| Application no. and date | 17722487.0 (espacenet) (Federated) (European Patent Register), 20170418 | | Patent/reg. no. and date | DK/EP 3445786, 20231004 | | Publication date | 20190227 | | Priority no. and date | FI 20165336, 20160418 | | EP pub. no. and date |
EP 3445786 20190227 | | Effective date | | | Applicant/owner | Faron Pharmaceuticals OY, Joukahaisenkatu 6
20520 Turku, FI | | Applicant ref. no. | | | Inventor | Jalkanen, Markku, Rauvolantie 77
20760 Piispanristi, FI,
MAKSIMOW, Mikael, Puhuri 11 G 23
20900 Turku, FI,
HOLLMÉN, Maija-Leena, Rauvolantie 79
20760 Piispanristi, FI,
VIITALA, Miro, Sirkkalankatu 6 B 24
20520 Turku, FI | | Representative | | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61P 35/00 (2006.01) , A61P 37/04 (2006.01) , C07K 16/28 (2006.01) , G01N 33/50 (2006.01) , G01N 33/68 (2006.01) | | Title | DIAGNOSIS OF IMMUNE_ACTIVATION USING CLEVER-1, TNF-ALPHA AND HLA-DR BINDING AGENTS | | Int. application no. | FI2017050286 | | Int. publication no. | WO2017182706 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
